Samenvatting
Heterogeneous immunoassays such as ELISA have become indispensable in modern bioanalysis, yet translation into point-of-care assays is hindered by their dependence on external calibration and multiple washing and incubation steps. Here, we introduce RAPPID (Ratiometric Plug-and-Play Immunodiagnostics), a mix-and-measure homogeneous immunoassay platform that combines highly specific antibody-based detection with a ratiometric bioluminescent readout. The concept entails analyte-induced complementation of split NanoLuc luciferase fragments, photoconjugated to an antibody sandwich pair via protein G adapters. Introduction of a calibrator luciferase provides a robust ratiometric signal that allows direct in-sample calibration and quantitative measurements in complex media such as blood plasma. We developed RAPPID sensors that allow low-picomolar detection of several protein biomarkers, anti-drug antibodies, therapeutic antibodies, and both SARS-CoV-2 spike protein and anti-SARS-CoV-2 antibodies. With its easy-to-implement standardized workflow, RAPPID provides an attractive, fast, and low-cost alternative to traditional immunoassays, in an academic setting, in clinical laboratories, and for point-of-care applications.
| Originele taal-2 | Engels |
|---|---|
| Artikelnummer | 4586 |
| Aantal pagina's | 12 |
| Tijdschrift | Nature Communications |
| Volume | 12 |
| Nummer van het tijdschrift | 1 |
| DOI's | |
| Status | Gepubliceerd - 28 jul. 2021 |
Bibliografische nota
© 2021. The Author(s).Financiering
| Financiers | Financiernummer |
|---|---|
| European Union’s Horizon Europe research and innovation programme | 677313 |
| European Union’s Horizon Europe research and innovation programme | |
| European Union’s Horizon Europe research and innovation programme | ERC-2016-PoC 755471, ERC-2011-StG 280255 |
| Nederlandse Organisatie voor Wetenschappelijk Onderzoek | RAAK.PRO02.066, 17820 |
Vingerafdruk
Duik in de onderzoeksthema's van 'A plug-and-play platform of ratiometric bioluminescent sensors for homogeneous immunoassays'. Samen vormen ze een unieke vingerafdruk.Pers/Media
-
A Molecular Traffic Light for Infectious Disease Testing
Merkx, M. & van Aalen, E. A.
28/07/21 → 6/08/21
2 items van Media-aandacht
Pers / media: Vakinhoudelijk commentaar
-
News A Molecular Traffic Light for Infectious Disease Testing Researchers have developed a sensor that uses a “glow-in-the-dark” signal to indicate the presence of tiny amounts of proteins and anti-drug antibodies, as well as COVID-19 spike proteins and a
Merkx, M. & van Aalen, E. A.
29/07/21
1 item van Media-aandacht
Pers / media: Vakinhoudelijk commentaar